Cargando…
Targeting Cancer Stem Cells with Differentiation Agents as an Alternative to Genotoxic Chemotherapy for the Treatment of Malignant Testicular Germ Cell Tumors
SIMPLE SUMMARY: Testicular germ cell tumors (TGCTs) are the most common solid malignancy in young men. Fortunately, these tumors are highly curable with conventional genotoxic chemotherapy. However, because these chemotherapeutics have significant short- and long-term side effects, less toxic treatm...
Autores principales: | Loehr, Amanda R., Pierpont, Timothy M., Gelsleichter, Eric, Galang, Anabella Maria D., Fernandez, Irma R., Moore, Elizabeth S., Guo, Matthew Z., Miller, Andrew D., Weiss, Robert S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122873/ https://www.ncbi.nlm.nih.gov/pubmed/33922599 http://dx.doi.org/10.3390/cancers13092045 |
Ejemplares similares
-
Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy.
por: Fosså, S. D., et al.
Publicado: (1990) -
Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours
por: McNeish, I A, et al.
Publicado: (2004) -
Unusually Located Stroke After Chemotherapy in Testicular Germ Cell Tumors
por: Martinez, Braulio Alexander, et al.
Publicado: (2015) -
Imaging of testicular germ cell tumours
por: Dalal, P U, et al.
Publicado: (2006) -
Testicular microlithiasis as a familial risk factor for testicular germ cell tumour
por: Coffey, J, et al.
Publicado: (2007)